You are here

Innovations in rTMS Treatment

Presenting: Innovations in rTMS Treatment

You’re invited to join the Clinical TMS Society for this installment of our Grand Rounds Webinar Series:
Innovations in rTMS Treatment

Learning objectives: 

1.    Learners will be able to identify conventional rTMS strategies to treat medication resistance depression.

2.    Learners will be able to identify novel brain mechanisms that may help to identify treatment resistant depression.

3.    Learners will be able to identify novel rTMS treatment strategies to treat depression when conventional approaches do not work.


Date & Time: Tuesday, June 4, 2019 | 5:00 PM (PDT) - 6:00 PM (PDT)

Format: LIVE

Cost: Members: $25 | Non-members $50 | Student Members FREE

Speakers: Jeff Daskalakis, PhD

Jeff Daskalakis is a Professor of Psychiatry at University of Toronto. He is presently the Temerty Chair in Therapeutic Brain Intervention and chief of the General Adult Psychiatry and Health Systems Division at CAMH. The Temerty Centre uses magnetic brain stimulation to study the role of cortical inhibition and plasticity as potential pathophysiological mechanisms in schizophrenia, depression and obsessive compulsive disorder. Dr. Daskalakis also conducts treatment studies using repetitive transcranial magnetic brain stimulation (rTMS) and magnetic seizure therapy (MST) for refractory symptoms in these disorders. He holds or has held NARSAD, CIHR, Brain Canada and NIMH operating awards and grants. He has also been awarded the Samarthji Lal Award in Mental Health Research from the Graham Boeckh Foundation. He is also a member of the Brain and Behavior Research Foundation Scientific Council. Finally, he has over 320 peer-reviewed publications and is an editorial board member for Biological Psychiatry and an Associate Editor for Clinical Neurophysiology

Acknowledgement of Commercial Support

No financial or in-kind commercial support was received for this educational activity.

Satisfactory completion 

Learners must complete an evaluation to receive a certificate of completion.  You must participate in the entire webinar; partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.   



In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Clinical TMS Society.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


Disclosure of Conflict of Interest

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.  All of these relationships were treated as a conflict of interest, and have been resolved.  (C7 SCS 6.1-­6.2, 6.5)


All individuals in a position to control the content of CE are listed below.


Fist Name

Last Name

Commercial Interest:Relationship



American Psychiatric Association Publishing:Other

Z. Jeff


Brainsway Inc:Research Grant Site Principal Investigator,Magventure:Research Grant Site Principal Investigator






Greenbrook TMS:Stock Shareholder







Questions? Email

June 4th, 2019 5:00 PM   through   6:00 PM
Phone: 845-392-3238
Grand Rounds Webinar
CTMSS Member $ 25.00
Non-Member $ 50.00
Grand Rounds Webinar
Grand Rounds Webinar Title Innovations in rTMS Treatment
Time Zone Pacific
Event Thumbnail

Help spread the word

Please help us and let your friends, colleagues and followers know about our page: Innovations in rTMS Treatment

You can also share the below link in an email or on your website.